Etsy Inc (NASDAQ:ETSY, ETR:3E2) shares moved higher as the online marketplace announced a key leadership change aimed at unifying its product and technology strategy.
The company said Rafe Colburn, its current chief technology officer, will expand his role to become chief product and technology officer.
Planet Labs (NYSE:PL) shares surged 38% to $9.04 in midday trading on Monday after the provider of daily data and insights about Earth reported better than expected financial results for its second quarter of 2026.
The company’s revenue for the period rose 20% year over year to a record $73.39 million, exceeding the analyst consensus estimate of $65.74 million, according to Bloomberg.
Summit Therapeutics PLC (NASDAQ:SMMT) shares dropped sharply on Monday following the release of mixed results from its Phase III HARMONi trial of ivonescimab, a potential lung cancer therapy.
The stock fell 23.4% to about $20 in the early afternoon.
Dick's Sporting Goods (NYSE:DKS) shares gained nearly 2% to about $225 in late-morning trading on Monday after the sporting goods retailer announced that it has completed its acquisition of Foot Locker.
Dick’s said the combined company will operate more than 3,200 stores plus e-commerce and digital businesses across 20 countries in North America, Europe, Asia, and Australia, plus a licensed store presence in Europe, the Middle East and Asia.
Robinhood Markets Inc (NASDAQ:HOOD) shares jumped 13% to about $115 in early trading on Monday, while shares of AppLovin Corp (NASDAQ:APP) gained 11% to about $543, following an announcement that both companies will be included in the S&P 500 stock index after its next rebalancing on September 22.
Meanwhile, shares of Strategy, formerly known as MicroStrategy Incorporated (NASDAQ:MSTR), fell nearly 3% to $327 after the Bitcoin accumulator was left out of the popular, broad-based stock index despite posting a profit in its last quarter.
EchoStar Corporation (Nasdaq: SATS) shares climbed 22% to $82 in early trading on Monday after the satellite and wireless company announced it has inked a $17 billion deal to sell spectrum licenses to SpaceX.
The definitive agreement consists of up to $8.5 billion in cash and up to $8.5 billion in SpaceX stock.
Shares in Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) jumped 19% on Monday after the biotech announced a manufacturing partnership to advance its experimental CAR-T therapy for acute myeloid leukaemia.
The London-listed group said it would work with Made Scientific, a US-based contract manufacturer specialising in cell therapies, to scale up production of HG-CT-1.